Tatva Chintan Pharma Chem Limited
NSE:TATVA.NS
856.35 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2020 Q4 | 2020 Q3 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 122.15 | -483.43 | 382.92 | -1,437.48 | 1,257.26 | -447.61 | 273.66 | -886.81 | 672.57 | -1,769.86 | 630.17 | -1,793.86 | 1,023.94 | 44.81 | 91.25 | -119.21 |
| Short Term Investments
| 32.25 | 966.86 | 137.41 | 2,874.96 | 184.98 | 895.22 | 206.42 | 1,773.62 | 247.81 | 3,539.72 | 1,105.24 | 3,587.72 | 770.75 | 8.43 | 8.09 | 238.42 |
| Cash and Short Term Investments
| 154.4 | 483.43 | 483.43 | 1,437.48 | 1,442.24 | 447.61 | 480.08 | 886.81 | 920.38 | 1,769.86 | 1,735.41 | 1,793.86 | 1,794.69 | 44.81 | 99.34 | 119.21 |
| Net Receivables
| 664 | 0 | 700.93 | 0 | 595.92 | 0 | 849.46 | 0 | 584.41 | 0 | 919.65 | 0 | 966.66 | 1,056.23 | 581.69 | 0 |
| Inventory
| 1,444.83 | 0 | 1,527.66 | 0 | 1,431.49 | 0 | 1,624.98 | 0 | 2,029.69 | 0 | 1,699.58 | 0 | 881.01 | 720.19 | 694.46 | 0 |
| Other Current Assets
| 835.84 | 0 | 267.04 | 0 | 173.23 | 0 | 129.32 | 0 | 367.13 | 0 | 4.21 | 0 | 256.14 | 21.27 | 165.19 | 0 |
| Total Current Assets
| 2,500.89 | 483.43 | 2,979.06 | 1,437.48 | 3,708.59 | 447.61 | 3,135.55 | 886.81 | 3,930.76 | 1,769.86 | 4,358.85 | 1,793.86 | 3,898.5 | 1,842.5 | 1,540.68 | 119.21 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 5,344.63 | 0 | 4,994.62 | 0 | 4,547.86 | 0 | 4,265.15 | 0 | 2,899.56 | 0 | 2,107.87 | 0 | 1,572.89 | 1,301.62 | 1,216.64 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 45.44 | 0 | 39.61 | 0 | 4.83 | 0 | 4.76 | 0 | 3.56 | 0 | 3.17 | 0 | 0.9 | 0.95 | 0.86 | 0 |
| Goodwill and Intangible Assets
| 45.44 | 0 | 39.61 | 0 | 4.83 | 0 | 4.76 | 0 | 3.56 | 0 | 3.17 | 0 | 0.9 | 0.95 | 0.86 | 0 |
| Long Term Investments
| 42.19 | 0 | 42.6 | 0 | -140.46 | 0 | -177.95 | 0 | -220.23 | 0 | -1,084.36 | 0 | -635.17 | 0 | 0 | 0 |
| Tax Assets
| 124.09 | 0 | 122.97 | 0 | 93.03 | 0 | 123.56 | 0 | 69.46 | 0 | 87.1 | 0 | 38.35 | 0 | 0 | 0 |
| Other Non-Current Assets
| 12.98 | -483.43 | 8.32 | -1,437.48 | 188.56 | -447.61 | 211.93 | -886.81 | 253.06 | -1,769.86 | 1,110.38 | -1,793.86 | 774.68 | 2.96 | 1.67 | -119.21 |
| Total Non-Current Assets
| 5,569.33 | -483.43 | 5,208.12 | -1,437.48 | 4,693.82 | -447.61 | 4,427.45 | -886.81 | 3,005.41 | -1,769.86 | 2,224.16 | -1,793.86 | 1,751.65 | 1,305.53 | 1,219.17 | -119.21 |
| Total Assets
| 8,070.22 | 0 | 8,187.18 | 0 | 8,402.41 | 0 | 7,563 | 0 | 6,936.17 | 0 | 6,583.01 | 0 | 5,650.15 | 3,148.03 | 2,759.85 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 266.03 | 0 | 450.31 | 0 | 212.66 | 0 | 321.88 | 0 | 370.59 | 0 | 445.13 | 0 | 325.78 | 474.77 | 354.17 | 0 |
| Short Term Debt
| 149.71 | 0 | 136.32 | 0 | 593.26 | 0 | 1,660.27 | 0 | 1,309.13 | 0 | 1,068.27 | 0 | 543.35 | 634.85 | 530.37 | 0 |
| Tax Payables
| 0 | 0 | 0.76 | 0 | 0 | 0 | 2.13 | 0 | 9.7 | 0 | 10.23 | 0 | 25.5 | 6.88 | 0 | 0 |
| Deferred Revenue
| 7.49 | 0 | 0.76 | 0 | 157.86 | 0 | 302.54 | 0 | 137.21 | 0 | 15.53 | 0 | 26.8 | 0 | 0 | 0 |
| Other Current Liabilities
| 255.01 | 0 | 209.24 | 0 | 136.74 | 0 | 76.65 | 0 | 166.61 | 0 | 185.4 | 0 | 87.58 | 70.53 | 85.62 | 0 |
| Total Current Liabilities
| 678.24 | 0 | 796.63 | 0 | 1,100.52 | 0 | 2,361.34 | 0 | 1,983.54 | 0 | 1,714.33 | 0 | 983.51 | 1,180.15 | 970.16 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 2.6 | 0 | 6.39 | 0 | 16.82 | 0 | 42.3 | 0 | 87.82 | 0 | 131.11 | 0 | 197.76 | 267.63 | 306.62 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | -271.41 | 0 | 0 | 0 | -72.86 | 0 | 0 | 0 | 0.17 | 0 | 0 | 0.17 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 271.41 | 0 | 0 | 0 | 126.61 | 0 | 0 | 0 | 6.34 | 0 | 0 | 20.78 | 0 | 0 |
| Other Non-Current Liabilities
| 13.34 | -7,370.82 | 13.34 | 0 | -16.82 | 0 | -42.3 | 0 | 5.49 | 0 | 0.17 | 0 | 4.67 | 19.66 | 35.79 | 0 |
| Total Non-Current Liabilities
| 15.94 | -7,370.82 | 19.73 | 0 | 28.27 | 0 | 53.75 | 0 | 93.31 | 0 | 137.79 | 0 | 202.43 | 308.24 | 342.41 | 0 |
| Total Liabilities
| 694.18 | -7,370.82 | 816.36 | 0 | 1,128.79 | 0 | 2,415.09 | 0 | 2,076.85 | 0 | 1,852.12 | 0 | 1,185.94 | 1,488.39 | 1,312.57 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,726.62 | 0 | 0 | 0 | 1,445.71 | 0 |
| Common Stock
| 233.92 | 0 | 233.92 | 0 | 233.92 | 0 | 221.65 | 0 | 221.65 | 0 | 221.65 | 0 | 221.65 | 200.88 | 80.35 | 0 |
| Retained Earnings
| 0 | 0 | 3,081.99 | 0 | 0 | 0 | 2,825.25 | 0 | 0 | 0 | 2,414.71 | 0 | 0 | 1,456.02 | 1,365.36 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 7,370.82 | 7,136.9 | 7,273.62 | 7,039.7 | 5,147.91 | 10.75 | 4,859.32 | 4,637.67 | 4,730.89 | 4.27 | 4,464.21 | 4,242.56 | 2.74 | 1.57 | 1,176.94 |
| Other Total Stockholders Equity
| 7,142.12 | 0 | -3,081.99 | 0 | 0 | 0 | 2,090.26 | 0 | 0 | 0 | -2,636.36 | 0 | 0 | 0 | -2,891.42 | 0 |
| Total Shareholders Equity
| 7,376.04 | 7,370.82 | 7,370.82 | 7,273.62 | 7,273.62 | 5,147.91 | 5,147.91 | 4,859.32 | 4,859.32 | 4,730.89 | 4,730.89 | 4,464.21 | 4,464.21 | 1,659.64 | 1,447.28 | 1,176.94 |
| Total Equity
| 7,376.04 | 7,370.82 | 7,370.82 | 7,273.62 | 7,273.62 | 5,147.91 | 5,147.91 | 4,859.32 | 4,859.32 | 4,730.89 | 4,730.89 | 4,464.21 | 4,464.21 | 1,659.64 | 1,447.28 | 1,176.94 |
| Total Liabilities & Shareholders Equity
| 8,070.22 | 7,370.82 | 8,187.18 | 7,273.62 | 8,402.41 | 5,147.91 | 7,563 | 4,859.32 | 6,936.17 | 4,730.89 | 6,583.01 | 4,464.21 | 5,650.15 | 3,148.03 | 2,759.85 | 1,176.94 |